Vol 10, No 10 (October 31, 2021): Translational Andrology and Urology

Original Article

Robotic ureteral reimplantation for the management of ureterovaginal fistula: four cases at a single center
Changwei Yuan, Jie Wang, Sida Cheng, Zhihua Li, Chunru Xu, Weijie Zhu, Shubo Fan, Kunlin Yang, Xuesong Li, Liqun Zhou
Histopathologic and clinical comparison of recurrent and non-recurrent urethral stricture disease treated by reconstructive surgery
Iryna V. Samarska, Hasan Dani, Trinity J. Bivalacqua, Arthur L. Burnett, Andres Matoso
A novel mHealth App (RyPros) for prostate cancer management: an accessibility and acceptability study
Gang Wang, Bing Wu, Jing Chen, Gang Yu, Danni Lin, Guoren Wang, Zhiming Bai
Should ureteroscopy be performed for patients after ureteral reconstruction with autologous onlay flap/graft?
Jie Wang, Shubo Fan, Hua Guan, Shengwei Xiong, Dengxiang Zhang, Bingwei Huang, Xiang Wang, Hongjian Zhu, Zhihua Li, Gengyan Xiong, Zhongyuan Zhang, Kunlin Yang, Xuesong Li, Liqun Zhou
A ureteral stricture disease score and classification system: correlation with upper urinary tract reconstructive surgery complexity
Weijie Zhu, Zhenpeng Zhu, Zhihua Li, Xinfei Li, Jianye Zhang, Yangyang Xu, Xiang Wang, Peng Zhang, Bingwei Huang, Chen Huang, Dengxiang Zhang, Hongjian Zhu, Xuesong Li, Jian Lin, Liqun Zhou
The impact of preoperative percutaneous nephrostomy as a treatment strategy before flexible ureteroscopy for impacted upper ureteral stones with hydronephrosis
Go Anan, Daisuke Kudo, Toshimitsu Matsuoka, Yasuhiro Kaiho, Makoto Sato
Radiological features of renal pelvic hemangioma: a case series
Huajun Yu, Weiying Sun, Jianjun Zhang
ISPRF: a machine learning model to predict the immune subtype of kidney cancer samples by four genes
Zhifeng Wang, Zihao Chen, Hongfan Zhao, Hao Lin, Junjie Wang, Ning Wang, Xiqing Li, Degang Ding
China county-based prostate specific antigen screening for prostate cancer and a cost-effective analysis
Zhiguo Zhang, Guoshu Liang, Peng Zhang, Zhongqi Zhao, Zhongnan He, Fengzhen Luo, Zhenqing Chen, Zongke Yang, Zhijie Zhang, Tao Xia, Xin Liu, Yong Zhang, Wei Ye
Quaking I-5 protein inhibits invasion and migration of kidney renal clear cell carcinoma via inhibiting epithelial-mesenchymal transition suppression through the regulation of microRNA 200c
Ruili Zhang, Wenguang Wang, Ainiwaer Aimudula, Songmei Lu, Pengfei Lu, Remila Aihaiti, Yongxing Bao
Development of a highly sensitive digital PCR assay to quantify long non-coding RNA MYU in urine samples which exhibited great potential as an alternative diagnostic biomarker for prostate cancer
Di Liu, Huming Yin, Yong Wang, Yang Cao, Jian Yin, Jianping Zhang, Huancai Yin, Xiaojun Zhao
Effects of radical cystectomy, radiotherapy, and chemotherapy on the risk of long-term heart-specific death in bladder cancer patients
Fuhan Yang, Cheng Li, Yadong Guo, Yang Yu, Shiyu Mao, Ruiliang Wang, Wentao Zhang, Aihong Zhang, Xudong Yao
Overexpressing IFITM family genes predict poor prognosis in kidney renal clear cell carcinoma
Ying Xu, Danqi Huang, Kun Zhang, Zengqi Tang, Jianchi Ma, Mansheng Zhu, Hui Xiong
Extreme body mass index is associated with poor survival outcomes after radical cystectomy: a retrospective cohort study in a Chinese population
Xin Huang, Shenye Jin, Shenghua Liu, Jiang Geng
Clinical effectiveness of microsurgical subinguinal varicocelectomy with enhanced recovery after surgery for varicocele
Xiaobin Wang, Ruipeng Wang, Qiang Du, Bochen Pan

Editorial on Management of Advanced Genitourinary Malignancies1

Preface to “Management of advanced genitourinary malignancies”
Tilman Todenhöfer

Original Article on Management of Advanced Genitourinary Malignancies1

KDM5D predicts response to docetaxel chemotherapy in metastatic castration resistant prostate cancer patients
Georg Schäfer, Nikola Bednarova, Axel Heidenreich, Helmut Klocker, Isabel Heidegger

Original Article on Management of Advanced Genitourinary Malignancies1

Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging—utilization of a short-pass filter to reduce technical pitfalls
Christopher Darr, Pedro Fragoso Costa, Claudia Kesch, Ulrich Krafft, Lukas Püllen, Nina Natascha Harke, Jochen Hess, Tibor Szarvas, Johannes Haubold, Henning Reis, Wolfgang Peter Fendler, Ken Herrmann, Jan Philipp Radtke, Boris Alexander Hadaschik, Stephan Tschirdewahn
ALP bouncing and LDH normalization in bone metastatic castration-resistant prostate cancer patients under therapy with Enzalutamide: an exploratory analysis
Katrin Schlack, Laura-Maria Krabbe, Kambiz Rahbar, Karoline Isenberg, Axel Semjonow, Andres Jan Schrader, Martin Boegemann
Oncological validation of bone turnover markers c-terminal telopeptide of type I collagen (1CTP) and peptides n-terminal propeptide of type I procollagen (P1NP) in patients with prostate cancer and bone metastases
Stefan Aufderklamm, Jörg Hennenlotter, Steffen Rausch, Cornelia Bock, Eva Erne, Christian Schwentner, Arnulf Stenzl

Editorial Commentary on Management of Advanced Genitourinary Malignancies1

A marrow-minded look at immune checkpoint blockade resistance in metastatic castration resistant prostate cancer
Nicolette M. Fonseca, Morgan E. Roberts, Alexander W. Wyatt

Original Article on Management of Advanced Genitourinary Malignancies1

Assessment of prognosis by established prognosis scores and physicians’ judgement in mRCC patients: an analysis of the STAR-TOR registry
Martin Boegemann, Peter Jürgen Goebell, Michael Woike, Johanna Buncke, Katrin Schlack, Andres Jan Schrader

Review Article on Management of Advanced Genitourinary Malignancies1

Narrative review of developing new biomarkers for decision making in advanced testis cancer
Lucia Nappi, Craig Nichols, Christian Kollmannsberger
Systemic treatment of penile squamous cell carcinoma—hurdles and hopes of preclinical models and clinical regimens: a narrative review
Anita Thomas, Luisa Matos do Canto Alvim, Claudia Aparecida Rainho, Eva Juengel, Roman Alexander Blaheta, Philippe E. Spiess, Silvia Regina Rogatto, Igor Tsaur

Disclosure:

1. The series “Management of Advanced Genitourinary Malignancies” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Tilman Todenhöfer served as the unpaid Guest Editor for the series.